Circulars

SEBI extends timelines for merchant banker compliance including SBU transfer and net worth requirements implementation.

SEBI Extends Compliance Timelines for Merchant Bankers Under 2025 Amendment Regulations.

SEBI Extends Compliance Timelines for Merchant Bankers Under 2025 Amendment Regulations

News

Dabur India Limited has informed the stock exchanges that the United States Food and Drug Administration (US FDA) has issued an Import Alert against certain drugs manufactured at its Silvassa facility.

Dabur India Faces US FDA Import Alert Over Silvassa Manufacturing Unit

JK Tyre & Industries Ltd received a Rajasthan stamp duty order related to the merger of Cavendish Industries Ltd and plans to appeal the penalty and interest charges.

JK Tyre Receives Rajasthan Stamp Duty Order, Plans Appeal Against Rs 4 Crore Penalty and Interest

Whirlpool paid a Rs 50,000 compounding fee to settle a packaging disclosure compliance issue under Andhra Pradesh's Legal Metrology regulations.

Whirlpool Settles Packaging Disclosure Issue, Pays Rs 50,000 Compounding Fee

Reliance Infrastructure faces a Rs 77.86 crore bank account lien after a Customs Appeals order, and plans to appeal the decision.

Reliance Infra Bank Accounts Face Rs 77.86 Crore Lien After Customs Appeals Order

5paisa receives an SCN from SEBI, proposing to cancel its registration as an investment adviser for not paying the prescribed fees under the SEBI (Investment Advisers) Regulations, 2013.

Explore Our Blogs

Stay updated with the latest insights, tips, and industry trends from our experts

SEBI Extends Compliance Timelines for Merchant Bankers Under 2025 Amendment Regulations

Dabur India Faces US FDA Import Alert Over Silvassa Manufacturing Unit

JK Tyre Receives Rajasthan Stamp Duty Order, Plans Appeal Against Rs 4 Crore Penalty and Interest

Whirlpool Settles Packaging Disclosure Issue, Pays Rs 50,000 Compounding Fee

Reliance Infra Bank Accounts Face Rs 77.86 Crore Lien After Customs Appeals Order

SEBI Proposes to Cancel 5paisa's Registration as Investment Adviser Over Non-Payment of Prescribed Fees